Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a progressive and devastating disease characterized by pulmonary artery vasoconstriction and vascular remodeling leading to vascular rarefaction with elevation of pulmonary arterial pressures and pulmonary vascular resistance. Often PAH will cause death from...

Descripción completa

Detalles Bibliográficos
Autor principal: Zolty, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380049/
https://www.ncbi.nlm.nih.gov/pubmed/34429666
http://dx.doi.org/10.2147/JEP.S236743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380049/
https://www.ncbi.nlm.nih.gov/pubmed/34429666
http://dx.doi.org/10.2147/JEP.S236743

Ejemplares similares